Literature DB >> 26217093

Gastric mucosa in Mongolian and Japanese patients with gastric cancer and Helicobacter pylori infection.

Takeshi Matsuhisa1, Yoshio Yamaoka1, Tomohisa Uchida1, Davaadorj Duger1, Battulga Adiyasuren1, Oyuntsetseg Khasag1, Tserentogtokh Tegshee1, Byambajav Tsogt-Ochir1.   

Abstract

AIM: To investigate the characteristics of gastric cancer and gastric mucosa in a Mongolian population by comparison with a Japanese population.
METHODS: A total of 484 Mongolian patients with gastric cancer were enrolled to study gastric cancer characteristics in Mongolians. In addition, a total of 208 Mongolian and 3205 Japanese consecutive outpatients who underwent endoscopy, had abdominal complaints, no history of gastric operation or Helicobacter pylori eradication treatment, and no use of gastric secretion inhibitors such as histamine H2-receptor antagonists or proton pump inhibitors were enrolled. This study was conducted with the approval of the ethics committees of all hospitals. The triple-site biopsy method was used for the histologic diagnosis of gastritis and H. pylori infection in all Mongolian and Japanese cases. The infection rate of H. pylori and the status of gastric mucosa in H. pylori-infected patients were compared between Mongolian and Japanese subjects. Age (± 5 years), sex, and endoscopic diagnosis were matched between the two countries.
RESULTS: Approximately 70% of Mongolian patients with gastric cancer were 50-79 years of age, and approximately half of the cancers were located in the upper part of the stomach. Histologically, 65.7% of early cancers exhibited differentiated adenocarcinoma, whereas 73.9% of advanced cancers displayed undifferentiated adenocarcinoma. The infection rate of H. pylori was higher in Mongolian than Japanese patients (75.9% vs 48.3%, P < 0.0001). When stratified by age, the prevalence was highest among young patients, and tended to decrease in patients aged 50 years or older. The anti-East-Asian CagA-specific antibody was negative in 99.4% of H. pylori-positive Mongolian patients. Chronic inflammation, neutrophil activity, glandular atrophy, and intestinal metaplasia scores were significantly lower in Mongolian compared to Japanese H. pylori-positive patients (P < 0.0001), with the exception of the intestinal metaplasia score of specimen from the greater curvature of the upper body. The type of gastritis changed from antrum-predominant gastritis to corpus-predominant gastritis with age in both populations.
CONCLUSION: Gastric cancer was located in the upper part of the stomach in half of the Mongolian patients; Mongolian patients were infected with non-East-Asian-type H. pylori.

Entities:  

Keywords:  Chronic inflammation; Gastric cancer; Glandular atrophy; Helicobacter pylori; Intestinal metaplasia; Japanese; Mongolian; Neutrophil activity; Non-East-Asian-type strain

Mesh:

Year:  2015        PMID: 26217093      PMCID: PMC4507111          DOI: 10.3748/wjg.v21.i27.8408

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Breast-feeding prevents Helicobacter pylori infection in early childhood.

Authors:  M Okuda; E Miyashiro; M Koike; S Okuda; K Minami; N Yoshikawa
Journal:  Pediatr Int       Date:  2001-12       Impact factor: 1.524

2.  Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening.

Authors:  Taiji Akamatsu; Shinya Ichikawa; Sadahide Okudaira; Shuichi Yokosawa; Yugo Iwaya; Tomoaki Suga; Hiroyoshi Ota; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2011-08-19       Impact factor: 7.527

3.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

4.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

Review 5.  Chronic disease prevention research in Central Asia, the Urals, Siberia and Mongolia - past, present and future.

Authors:  Malcolm A Moore; Gulmira Aitmurzaeva; Zhetkergen A Arsykulov; Maratbek Bozgunchiev; Saule Alkeeva Dikanbayeva; Gulnara Igisinov; Nurbek Igisinov; Saginbek Igisinov; Sholpan Karzhaubayeva; Dondov Oyunchimeg; Tsendsuren Oyunsuren; Mashhura Soipova; T Tumubaatar
Journal:  Asian Pac J Cancer Prev       Date:  2009

6.  Cancer incidence and mortality in Mongolia - National Registry Data.

Authors:  Tuvshingerel Sandagdorj; Erdenechimeg Sanjaajamts; Undarmaa Tudev; Dondov Oyunchimeg; Chimedsuren Ochir; David Roder
Journal:  Asian Pac J Cancer Prev       Date:  2010

7.  Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.

Authors:  Kazutoshi Fukase; Mototsugu Kato; Shogo Kikuchi; Kazuhiko Inoue; Naomi Uemura; Shiro Okamoto; Shuichi Terao; Kenji Amagai; Shunji Hayashi; Masahiro Asaka
Journal:  Lancet       Date:  2008-08-02       Impact factor: 79.321

8.  Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection.

Authors:  Hee Jin Kim; Nayoung Kim; Hyun Young Kim; Hye Seung Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Do Joong Park; Hyung Ho Kim; Kyoung-Ho Lee; Young-Hoon Kim; Hee Man Kim; Dong Ho Lee
Journal:  Gastric Cancer       Date:  2014-09-21       Impact factor: 7.370

9.  [Chronological trend in clinicopathological characteristics of gastric cancer].

Authors:  Masayoshi Yamada; Ichiro Oda; Hirokazu Taniguchi; Ryoji Kushima
Journal:  Nihon Rinsho       Date:  2012-10

10.  Observation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and Japan, the country with the highest incidence.

Authors:  Takeshi Matsuhisa; Hafeza Aftab
Journal:  Helicobacter       Date:  2012-07-02       Impact factor: 5.753

View more
  7 in total

1.  New observations regarding Helicobacter pylori and gastric cancer in Mongolia.

Authors:  Boldbaatar Gantuya; Dashdorj Bolor; Khasag Oyuntsetseg; Yansan Erdene-Ochir; Ruvjir Sanduijav; Duger Davaadorj; Tegshee Tserentogtokh; Dashdorj Azzaya; Tomohisa Uchida; Takeshi Matsuhisa; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2018-06-08       Impact factor: 5.753

2.  Differences in the Association Between Modifiable Lifestyle Factors and Gastric Precancerous Lesions Among Mongolians and Han Chinese.

Authors:  Weiwei Wang; Liying Qiao; Weiqi Dong; Jing Ren; Xiaotian Chang; Siyan Zhan; Peng Du; Yunfeng Xi; Shengfeng Wang
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

3.  Incidence of Stomach and Esophageal Cancers in Mongolia: Data from 2009 to 2018.

Authors:  Tulgaa Lonjid; Tsegmed Sambuu; Nasanjargal Tumurbat; Ulziisaikhan Banzragch; Ganchimeg Dondov; Tegshjargal Badamjav; Bayar Davaa; Bolor-Erdene Tudev; Batbold Batsaikhan
Journal:  Euroasian J Hepatogastroenterol       Date:  2020 Jan-Jun

Review 4.  Different Pathophysiology of Gastritis in East and West? A Western Perspective.

Authors:  Hans-Peter Wirth; Manqiao Yang
Journal:  Inflamm Intest Dis       Date:  2016-05-14

5.  Prevalence, risk factors, and virulence genes of Helicobacter pylori among dyspeptic patients in two different gastric cancer risk regions of Thailand.

Authors:  Phawinee Subsomwong; Muhammad Miftahussurur; Tomohisa Uchida; Ratha-Korn Vilaichone; Thawee Ratanachu-Ek; Varocha Mahachai; Yoshio Yamaoka
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240

Review 6.  The role of integrating conjugative elements in Helicobacter pylori: a review.

Authors:  Langgeng Agung Waskito; Jeng Yih-Wu; Yoshio Yamaoka
Journal:  J Biomed Sci       Date:  2018-11-29       Impact factor: 8.410

7.  Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions.

Authors:  Boldbaatar Gantuya; Hashem B El Serag; Takashi Matsumoto; Nadim J Ajami; Tomohisa Uchida; Khasag Oyuntsetseg; Dashdorj Bolor; Yoshio Yamaoka
Journal:  Aliment Pharmacol Ther       Date:  2020-03-04       Impact factor: 8.171

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.